These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15470202)

  • 1. Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load.
    Devincenzo JP
    Pediatr Res; 2004 Dec; 56(6):914-7. PubMed ID: 15470202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity.
    Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F
    J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus load predicts disease severity in previously healthy infants.
    DeVincenzo JP; El Saleeby CM; Bush AJ
    J Infect Dis; 2005 Jun; 191(11):1861-8. PubMed ID: 15871119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.
    Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP;
    Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody.
    DeVincenzo JP; Aitken J; Harrison L
    J Pediatr; 2003 Jul; 143(1):123-6. PubMed ID: 12915838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for control of respiratory syncytial virus infection.
    Nokes JD; Cane PA
    Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between respiratory syncytial virus genotype and severity of illness.
    Martinello RA; Chen MD; Weibel C; Kahn JS
    J Infect Dis; 2002 Sep; 186(6):839-42. PubMed ID: 12198620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.
    Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL
    Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years.
    Matheson JW; Rich FJ; Cohet C; Grimwood K; Huang QS; Penny D; Hendy MD; Kirman JR
    J Med Virol; 2006 Oct; 78(10):1354-64. PubMed ID: 16927286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
    Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
    Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
    Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
    Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children.
    Kim YI; Murphy R; Majumdar S; Harrison LG; Aitken J; DeVincenzo JP
    Pediatr Res; 2015 Oct; 78(4):380-8. PubMed ID: 26107392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection.
    van Woensel JB; Lutter R; Biezeveld M; Dekker T; Nijhuis M; van Aalderen WM; Kuijpers TW
    Pediatr Infect Dis J; 2003 Aug; 22(8):721-6. PubMed ID: 12913774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severity of respiratory syncytial virus infection influenced by clinical risk factors and subtype A and B in hospitalized children].
    Bergsträsser E; Zbinden R; Minder C; Gnehm HE
    Klin Padiatr; 1998; 210(6):418-21. PubMed ID: 9871899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equal virulence of rhinovirus and respiratory syncytial virus in infants hospitalized for lower respiratory tract infection.
    Van Leeuwen JC; Goossens LK; Hendrix RM; Van Der Palen J; Lusthusz A; Thio BJ
    Pediatr Infect Dis J; 2012 Jan; 31(1):84-6. PubMed ID: 21909047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants.
    Buckingham SC; Bush AJ; Devincenzo JP
    Pediatr Infect Dis J; 2000 Feb; 19(2):113-7. PubMed ID: 10693996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome.
    Buckingham SC; Jafri HS; Bush AJ; Carubelli CM; Sheeran P; Hardy RD; Ottolini MG; Ramilo O; DeVincenzo JP
    J Infect Dis; 2002 May; 185(9):1222-8. PubMed ID: 12001038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
    Henckel E; Luthander J; Berggren E; Kapadia H; Naver L; Norman M; Bennet R; Eriksson M
    Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.